Point72 Europe’s Halozyme HALO Stock Holding History

Point72 Europe’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-29,335	Closed	-$1.4M	–	149
2024 Q4	$1.4M	Buy	+29,335	New	+$1.5M	0.08%	114
2024 Q1	–	Sell	-261	Closed	-$9.65K	–	248
2023 Q4	$9.65K	Buy	+261	New	+$9.83K	﹤0.01%	406

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Point72 Europe's HALO Position: Q1 2025 in Review

Point72 Europe sold out of Halozyme (HALO) in Q1 2025, closing a stake of 29,335 shares — an estimated $1.4M sold.

Point72 Europe first reported a position in HALO in Q4 2023 and held it in 2 quarters. The position peaked at $1.4M in Q4 2024. 550 funds tracked by Wall St. Rank hold HALO as of Q1 2025.

Point72 Europe reported no remaining Halozyme position as of Q1 2025 after selling out during the quarter.
Point72 Europe sold 29,335 Halozyme shares in Q1 2025, an estimated $1.4M.
Point72 Europe first reported a position in Halozyme in Q4 2023 and held it in 2 quarters.
Point72 Europe's Halozyme position peaked at $1.4M in Q4 2024.
550 funds tracked by Wall St. Rank held Halozyme as of Q1 2025.

Based on Point72 Europe's 13F filing for Q1 2025, filed 15 May 2025.